Two Schedule 13G forms filed with the SEC yesterday called my attention. One of them was presented by Jacob Gottlieb’s Visium Asset Management, which disclosed a 25% increase in its exposure to Wright Medical Group Inc (NASDAQ:WMGI). The fund now owns 3.05 million shares of Common Stock, which account for 6.1% of the company’s shares outstanding. Also yesterday, James E. Flynn’s Deerfield Management made public a new position, with 1.45 million shares of Common Stock, at Trupanion Inc (NYSE:TRUP). This wage represents more than 5.2% of the company’s outstanding Common Stock.
Wright Medical Group Inc (NASDAQ:WMGI) is a $1.5 billion market cap global orthopaedic medical device company that designs, manufactures and markets reconstructive joint devices and biologic products for extremity, hip and knee repair and reconstruction. According to its latest 13G filing, Visium Asset Management augmented its exposure to the company by more than 25% in late-September. The fund currently owns more than 3.05 million shares of Common Stock, which account for 6.1% of the company’s outstanding stock, and are worth more than $94 million at current stock prices.
In addition to Visium Asset Management, which is one of the largest institutional shareholders in the company, other funds like Arthur B Cohen And Joseph Healey’s Healthcor Management Lp and Ken Fisher’s Fisher Asset Management are also betting on Wright Medical Group Inc (NASDAQ:WMGI). By the end of the second quarter of 2014, the first fund held 3.15 million shares of the company, while the latter acknowledged owning 2.38 million shares.
Trupanion Inc (NYSE:TRUP) is a $225 million market cap direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico, which IPOed in July. Also on late-September, James E. Flynn’s Deerfield Management started a stake in the company, with 1.45 million shares of Common Stock, which accounted for approximately 5.24% of Trupanion Inc (NYSE:TRUP)’s outstanding stock, and are worth more than $11 million at current stock prices.
According to out database, Deerfield Management is the first institutional investor (amongst those we keep track of) to acquire, or at least disclose, a stake in Trupanion Inc (NYSE:TRUP).
Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned
Free Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks
Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.